1-10 of 10
Miki Nakamura
Close
Sort by
Journal Articles

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

Masataka Takeshita, MD PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD PhD, Shotaro Hagiwara, MD PhD, Akiyoshi Miwa, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5837.
https://doi.org/10.1182/blood.V124.21.5837.5837
Published: 2014
Journal Articles

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2171.
https://doi.org/10.1182/blood.V122.21.2171.2171
Published: 2013
Journal Articles

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

Sohtaro Mine, MD, Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD, Toru Igari, MD PhD
Journal: Blood
Blood (2013) 122 (21): 5321.
https://doi.org/10.1182/blood.V122.21.5321.5321
Published: 2013
Journal Articles

What Is the Appropriate Dose Attenuation System of RCHOP for Elderly DLBCL Patients? - A Single Institutional Analysis in 115 Cosecutive Patients From Japan -

Akira Tanimura, MD, Risen Hirai, MD, Atsushi Sato, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Shotaro Hagiwara, MD, PhD, Akiyoshi Miwa, MD
Journal: Blood
Blood (2012) 120 (21): 3639.
https://doi.org/10.1182/blood.V120.21.3639.3639
Published: 2012
Journal Articles

High-Dose Cyclophosphamide + G-CSF Mobilization Regimen Have Higher Anti-Myeloma Effects Than G-CSF Alone Regimen – Single Institutional Study in 147 Myeloma Patients From Japan

Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Atsushi Sato, MD, Junichiro Takano, MD, Hideaki Kitahara, MD, Ayato Tsukamoto, MD, Yuko Kimura, MD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Shotaro Hagiwara, MD, PhD, Mineo Kurokawa, MD, PhD, Akiyoshi Miwa, MD
Journal: Blood
Blood (2011) 118 (21): 2007.
https://doi.org/10.1182/blood.V118.21.2007.2007
Published: 2011
Journal Articles

CD125-Expressing Myeloma: A Subgroup of Multiple Myeloma (MM) with Immature Phenotype, Endoplasmic Reticulum Stress Response and Low Sensitivity to Bortezomib

Yawara Kawano, Yoshitaka Kikukawa, Miki Nakamura, Yutaka Okuno, MD, PhD, Hiromichi Yuki, Shiho Fujiwara, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 616.
https://doi.org/10.1182/blood.V116.21.616.616
Published: 2010
Journal Articles

Acute Promyelocytic Leukemia Harboring STAT5b-RAR α Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene.

Eisaku Iwanaga, Miki Nakamura, Tomoko Nanri, Toshiro Kawakita, Naofumi Matsuno, Koyu Hoshino, Kentaro Horikawa, Hiroaki Mitsuya, Norio Asou
Journal: Blood
Blood (2007) 110 (11): 4227.
https://doi.org/10.1182/blood.V110.11.4227.4227
Published: 2007
Journal Articles

Clarithromicin Induces Autophagy in Myeloma Cells.

Miki Nakamura, MD, PhD, Takahiro Kamimoto, PhD, Tamotsu Yoshimori, PhD, Hiroaki Mitsuya, MD PhD, Hiroyuki Hata, MD PhD
Journal: Blood
Blood (2006) 108 (11): 3509.
https://doi.org/10.1182/blood.V108.11.3509.3509
Published: 2006
Journal Articles

Kigamicin Induces Necrosis to Human Myeloma Cells by Disruption of Cell Cycle Regulation.

Miki Nakamura, MD, PhD, Hiroyasu Esumi, MD PhD, Jie Lu, PhD, Hiroaki Mitsuya, MD PhD, Hiroyuki Hata, MD PhD
Journal: Blood
Blood (2006) 108 (11): 5017.
https://doi.org/10.1182/blood.V108.11.5017.5017
Published: 2006
Journal Articles

Induction of Autophagy to Myeloma Cells by Thalidomide and Clarithromycin.

Miki Nakamura, Takahiro Kamimoto, Tamotsu Yoshimori, Yutaka Okuno, Motohiro Takeya, Hiroaki Mitsuya, Hiroyuki Hata
Journal: Blood
Blood (2005) 106 (11): 5134.
https://doi.org/10.1182/blood.V106.11.5134.5134
Published: 2005